In addition, Wang et al. (2020) [95] found that lung cancer cells overexpressing FGFRL1 showed decreased metastatic ability, whereas silencing FGFRL1 increased the metastatic ability of lung cancer cells. This evidence concerns the gene FGFRL1 and lung carcinoma.